Cora Gold Ltd (LON: CORA) have seen their shares jump on Thursday afternoon, following a mineral resource estimation for its operations in Mali.

Cora Gold is a gold exploration company focused on two world class gold regions in Mali and Senegal in West Africa. Historical exploration has resulted in the highly prospective Sanankoro Gold Discovery, in addition to multiple, high potential, drill ready gold targets within its broader portfolio.

Cora Gold’s primary focus is on further developing Sanankoro in the Yanfolila Gold Belt (southern Mali), which Cora Gold believes has the potential for a standalone mine development.

Shares in Cora Gold jumped 2.43% to 5p. 5/12/19 15:00BST.

Cora Gold have seen a very productive few months, with shares being sustainably in green. In July, the firm saw its shares in green after they announced an extension of high grade gold mineralisation at its Sanankoro Gold Discovery in Southern Mali.

A few weeks after, Cora again pulled it out of the bag as it reported progress at its Selin project at the Sanankoro Gold Discovery in Southern Mali.

The Company said that gold oxide mineralisation extended up to depth of 90 metres. They recorded potential commercial mineralisation subsections of 25 metres at 2.81 g/t, 19 metres at 1.61 g/t and 9 metres at 2.37 g/t.

Today, the firm said it has received a maiden pit constrained mineral resource estimate from independent consultants SRK Consulting UK Ltd for its Sanankoro gold project in southern Mali.

Chief Executive Jonathan Forster said: “This estimate is the first step in defining the overall oxide potential at the project, where to date less than a quarter of the one to two million ounces SRK exploration target has been tested.”

“We have also been able to include a small amount of sulphide material in the mineral resource estimate, confirming our belief that exploration expansion into the sulphide zones could provide significant future upside,” Forster said.

Whereas the gold recovery from oxides is shown to range from 92.9% to 95.7%, the sulphide resource estimate has assumed an 80% extraction rate for gold recovery. This has been determined on the basis of “very preliminary” metallurgical testing of two sulphide samples, Cora noted.

One test was conducted on sulphide core to provide a preliminary indication of the hardness of the sulphide ore, the company said, with results showing that the sulphide ore is “moderately hard”.

The gold mining sector has been very busy this week, and firms have seen their shares become volatile.

The mineral and mining sector has been busy this week, as FTSE100 Fresnillo saw their shares in red on Monday as the firm cut its 2019 production estimates.

Additionally, FTSE250 listed Centamin PLC have seen their shares in green following an unanimous board rejection of a hostile takeover approach by rival Endeavour Mining.

MJ Gleeson PLC (LON: GLE) have seen their shares in red despite a confident update to shareholders posted on Thursday.

MJ Gleeson Group plc founded in 1903 specializes in urban regeneration and land development. It has public facing divisions, Gleeson Homes and Gleeson Strategic Land.

Shares in MJ Gleeson fell 0.77% on Thursday afternoon to 811p. 5/12/19 14:18BST.

In July, the firm saw its shares rally on record performance across all divisions. The firm saw strong sales growth following higher demand for home for sale in Northern England and the Midlands.

The positive update added that Gleeson Homes is currently active on 69 sites and expects to grow to 80 sites in the coming year. It is also on track to achieve its goal of doubling its volumes to 2,000 new homes per year by 2022.

Today, the firm said it expects to deliver annual results in line with forecasts backed up by a strong performance by its Home unit.

The house builder said it has experienced a “strong” demand at its Homes division, with net reservations since the start of its current financial year up more than 10% compared with the same period last year.

Gleeson said Homes has a pipeline of 13,042 plots with a gross development value of £1.7 billion, of which 6,910 plots are owned and 6,132 are conditionally purchased.

“Strong demand, good mortgage availability and our ability to offer attractive levels of affordability to our customers, means the outlook for the division remains very positive,” said Chair Dermot Gleeson.

“Against this background the board remains confident that the group’s results for financial 2020 will be in line with expectations,” added Dermot Gleeson.

The firm said it expects the Homnes unit to record an increase in completions for the first half of 10%, with the previous half year total being 691 units.

For its financial year to the end of June 2020, the company said it plans to deliver an increase in completions of at least 10% versus prior year’s 1,529 units.

In the Strategic Land division, the firm saw strong demand for consented land. Gleeson said it expects results for the first half to be lower than usual, as the majority of land sales are expected in the second half of financial 20.

The struggling nature of the UK homebuilding industry is one that has been seen for many firms, however competitors do seem to be making ground.

FTSE250 listed Homeserve saw their shares rally in November. The firm saw a 2% rise in pretax from £19.3 million to £19.7 million, which caught shareholders attention.

A notable merger in the sector also came from Galliford Try and Bovis Homes Group plc, who had agreed a homebuilding deal which saw Bovis takeover the two Galliford housebuilding business units which was valued at £1.14 billion.

Regency Mines Plc (LON: RGM) have announced the plan to issue a share placing scheme as part of its company overhaul.

Regency Mines plc (“the Company” or “Regency”) is a small cap natural resource exploration and development listed company on the Alternative Investment Market of the London Stock Exchange Ltd in London.

Regency updated shareholders at the start of July about its Metallurgical coal interest. The firm saw its shares dip more than 5% following an investment of $750,000 on behalf of clients of White November for a 45.02% interest in MET as well as a seat on the board.

Today, Regency have given shareholders an update about the plans to restructure the company including board changes, share placing and share consolidation.

Regency also said that C4 Energy Ltd, a UK incorporated private company, part controlled by proposed new chair James Parsons, has secured an option to acquire Regency’s remaining debt.

Regency has proposed to raise £831,000 via a placing of 3.02 billion new shares at a price of 0.0275p each. Alongside the placing, an additional 530.0 million shares, representing obligations of £145,785, have been issued to Red Rock Resources PLC (LON: RRR) in “full extinguishment of outstanding obligations”.

The company also said partial conversion of promissory notes will result in the issue of 2.60 billion shares, while holders of £281,113 in outstanding convertible loan notes have agreed to convert these into 1.02 billion shares.

This announcement will mean that the company will have 8.69 billion shares in current issue.

“The directors consider that it is in the best interests of the company’s long-term development as a publicly quoted company to have a smaller number of shares in issue and a higher share price,” the company said.

Following the announcement of changes at the firm, shareholders seem to have been kept on their toes.

Shares of Regency rallied 29.23% following the announcement, and trade at 0.042p. 5/11/19 13:58BST

The firm also announced James Parsons proposing to join Regency as Executive Chairman.

James Parsons, proposed Executive Chairman, commented: “The road to a successful carbon transition requires real progress in the exploration and extraction of battery metals and energy storage technology. I see huge opportunity for Regency given its current asset base, particularly supporting the recent rapid growth of Electric Vehicles, and I am delighted to join as Executive Chairman with a view to building the business through a blend of organic development and acquisition.”

Nigel Burton, outgoing Non-Executive Chairman, commented: “These developments are the culmination of a multi-month effort to establish the foundations of growth and value creation for Regency. We welcome James Parsons joining as part of the restructuring process, and we look forward to a renewed focus on project development under his leadership.”

The mineral and mining sector has been busy this week, as FTSE100 Fresnillo saw their shares in red on Monday as the firm cut its 2019 production estimates.

Fresnillo aid it expects to produce 885,000 ounces of gold and 55 million ounces of silverm which was down from the 880,000 ounces to 910,000 ounces which was once guided.

GlaxoSmithKline plc (LON: GSK) have seen their shares modestly boosted on Thursday afternoon following an announcement by the firm on a drug application in the United States.

GlaxoSmithKline have seen a relatively positive 2019 with the firm giving shareholders good updates across the year.

In July, the firm announced that it would be appointing HBSC’s Jonathan Symonds as the Non-Executive Chairman of the Board.

Shareholders were optimistic about the update, as Symonds had prior experience working in the pharmaceuticals industry working with firms such as AstraZeneca (LON: AZN) – who notably updated the market this morning about the approval of a Chinese marketing campaign.

Additionally, at the end of October the FTSE100 listed firm then gave shareholders an impressive update which saw a lift in their annual profit forecasts as the firm impressively told shareholders that turnover rose 11% to £9.39 billion in the three months ended Sept. 30 from a year earlier.

Today, the firm said that ViiV Healthcare has completed submission of a new drug application to the US Food & Drug Administration, seeking approval of fostemsavir.

ViiV Healthcare is majority owned by GSK, with rival firms Pfizer Inc (NYSE: PFE) and Shionogi Ltd (TYO: 4507) as a minority shareholders.

Fostemsavir is an investigational attachment inhibitor for the treatment of HIV-1 infection, which is being developed for use in combination with other antiretroviral agents in heavily treatment-experienced adults.

“Fostemsavir may provide an important treatment option for the group of people living with HIV who, for a variety of reasons, are not able to suppress their virus with other medicines and could be left with few or no treatments available to them,” said ViiV Healthcare Chief Executive Deborah Waterhouse.

She added: “In keeping with our mission of leaving no person with HIV behind, we have overcome many barriers to bring this important new medicine to people living with HIV, including investing in what is a very complex manufacturing process.”

Shareholders of Victrex plc (LON: VCT) have seen a dip in their shares on Thursday afternoon, after a modest update was provided.

Victrex plc is a British-based supplier of high performance polymer solutions. The company’s headquarters and manufacturing facilities are based in the UK with technical and customer support facilities in multiple markets, serving more than 40 countries

Shares of Victrex PLC saw a 0.77% dip on the announcement, and trade at 2,324p. 5/12/19 13:07BST.

Victrex reported that it saw a sharp drop in revenue and profit following weak sales performance.

As a result, the FTSE250 listed firm cut its dividend, which will come as alarming news to shareholders.

In the twelve months to September 30, Victrex recorded pretax profit of £104.7 million, down 18% on the £127.5 million reported the year before. Additonally, Revenue fell 9.8% year on year to £294.0 million from £326.0 million.

The company lowered its total dividend per year to 59.56 pence, down 58% on the 142.24p distributed the year before.

“Our full year performance was in line with expectations, with good growth in Aerospace, Energy and Medical being offset by a deterioration during the second half in Automotive, Electronics and Value Added Resellers, although these end markets are gradually stabilising,” said Chief Executive Jakob Sigurdsson.

Victrex saw a 15% drop in group sales to 3,751 tonnes from 4,407 tonnes the year before.

The company explained: “This reflects the cyclicality in Automotive and the associated impact on our Value Added Resellers segment, together with some de-stocking, with supply chain inventories running very low.”

The company also noted the “weaker” Electronics market, with both the semiconductor and smartphone markets down.

Victrex said a further headwind was the “tough” year on year comparative in its Consumer Electronics business, where it signed a large contract in the prior year. Excluding that contract, total group sales are down 12%.

Sigurdsson continued: “Pleasingly, we saw further progress in our new product pipeline and mega-programmes. We secured our first commercial order for Aerospace composite parts, we signed a new long-term development alliance with Airbus to support larger Primary and Secondary structures, and we saw strong growth in our next generation PEEK-OPTIMA HA Enhanced product for the Spine market. In PEEK Gears, our value proposition is strong and we have multiple development programmes underway, as well as gears on the road.”

Victrex said it remains “cautious” in its near term outlook.

“Looking forward, Automotive and Electronics are showing signs of stability, although we will retain some caution on these markets at this early stage, with an initial assumption that current trends will continue through the first half year,” Sigurdsson said.

He added: “Our cost-effective de-bottlenecking project is underway, enabling Victrex to gain significant incremental capacity in support of our medium-term growth programmes, although an extended shutdown will mean some under recovered overheads. On a full year basis, currency offers a modest tailwind although this will be offset to a large degree by some limited incremental operating investment, cost inflation and our employee bonus scheme. Overall, we remain focused on making year-on-year progress and our Polymer & Parts strategy keeps us well placed to deliver our medium to long term growth opportunities.”

The results from Victrex come as no surprise when we look at one of the main markets that Victrex supply to. If we look at a couple cases, the results start to become familiar.

Nissan (TYO: 7201) saw their shares slide on November 13, as the firm cut its full year forecast. Nissan alluded to slumping demand and tough market conditions as a hamper to business.

Additionally, Renault saw its shares in red after the firm cut its 2019 guidance as a result of “less favourable” economic environment, Renault joined rivals such as Suzuki who saw their sales crash following a global slump and poor performance.

Considering the nature of the updates in the automotive industry, the results will have come as no surprise to Victrex.

Once market trading eases up following Brexit clarifications and the resolving of the US China trade war, shareholders may see shares in green. However, this will be a waiting game and patience will be needed for shareholders to allow Victrex to recover.